Annie Warsi

Annie Warsi, MD, MAS is Senior Director, Clinical Development at Priovant Therapeutics. Annie is a pharmaceutical industry physician who brings extensive experience in clinical development, clinical research methods, and regulatory filings, including two approved indications in the US and EU. She joins Priovant from Mirum Pharmaceuticals where she was Medical Director, Clinical Development and led clinical trials of ileal bile acid transport inhibitors (IBATi) in hepatology/immunology and obstetrics indications. Prior to that role, Annie spent three years at Myovant Sciences, where she provided leadership and medical oversight for the company's two phase 3 clinical development programs for relugolix combination therapy.

Annie holds an MBBS/MD from Ziauddin Medical College and a MAS in Clinical Research from the University of California, San Francisco.